Mendoza JT - Search Results

1

Camptothecin derivatives induce regression of human ovarian carcinomas grown in nude mice and distinguish between non-tumorigenic and tumorigenic cells in vitro.

Pantazis P, Kozielski AJ, Mendoza JT, Early JA, Hinz HR, Giovanella BC. Pantazis P, et al. Among authors: mendoza jt. Int J Cancer. 1993 Mar 12;53(5):863-71. doi: 10.1002/ijc.2910530526. Int J Cancer. 1993. PMID: 8449612

2

Structure-activity relationship of alkyl 9-nitrocamptothecin esters.

Cao ZS, Pantazis P, Mendoza J, Early J, Kozielski A, Harris N, Giovanella B. Cao ZS, et al. Acta Pharmacol Sin. 2003 Feb;24(2):109-19. Acta Pharmacol Sin. 2003. PMID: 12546717 Free article.

3

Anticancer activity of new haloalkyl camptothecin esters against human cancer cell lines and human tumor xenografts grown in nude mice.

Cao Z, Mendoza J, Kozielski A, Liu X, Dejesus A, Wang Y, Zhan CG, Vardeman D, Giovanella B. Cao Z, et al. Anticancer Agents Med Chem. 2012 Sep;12(7):818-28. doi: 10.2174/187152012802650219. Anticancer Agents Med Chem. 2012. PMID: 22583427

4

Sensitivity of camptothecin-resistant human leukemia cells and tumors to anticancer drugs with diverse mechanisms of action.

Pantazis P, Vardeman D, Mendoza J, Early J, Kozielski A, DeJesus A, Giovanella B. Pantazis P, et al. Leuk Res. 1995 Jan;19(1):43-55. doi: 10.1016/0145-2126(94)00060-n. Leuk Res. 1995. PMID: 7837817

5

Development of resistance to 9-nitro-camptothecin by human leukemia U-937 cells in vitro correlates with altered sensitivities to several anticancer drugs.

Pantazis P, Mendoza J, DeJesus A, Early J, Shaw M, Giovanella BC. Pantazis P, et al. Anticancer Drugs. 1994 Aug;5(4):473-9. doi: 10.1097/00001813-199408000-00014. Anticancer Drugs. 1994. PMID: 7949254

6

Structure-activity relationship of alkyl camptothecin esters.

Cao Z, Pantazis P, Mendoza J, Early J, Kozielski A, Harris N, Vardeman D, Liehr J, Stehlin JS, Giovanella B. Cao Z, et al. Ann N Y Acad Sci. 2000;922:122-35. doi: 10.1111/j.1749-6632.2000.tb07031.x. Ann N Y Acad Sci. 2000. PMID: 11193888

7

Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins.

Pantazis P, Hinz HR, Mendoza JT, Kozielski AJ, Williams LJ Jr, Stehlin JS Jr, Giovanella BC. Pantazis P, et al. Among authors: mendoza jt. Cancer Res. 1992 Jul 15;52(14):3980-7. Cancer Res. 1992. PMID: 1617674

8

Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouse.

Verschraegen CF, Mendoza JT, Kozielski AJ, Giovanella BC. Verschraegen CF, et al. Among authors: mendoza jt. Anticancer Res. 1995 Jan-Feb;15(1):9-11. Anticancer Res. 1995. PMID: 7733648

9

Partial characterization of human leukemia U-937 cell sublines resistant to 9-nitrocamptothecin.

Pantazis P, Mendoza JT, DeJesus A, Rubin E, Kufe D, Giovanella BC. Pantazis P, et al. Among authors: mendoza jt. Eur J Haematol. 1994 Sep;53(3):135-44. doi: 10.1111/j.1600-0609.1994.tb00661.x. Eur J Haematol. 1994. PMID: 7925856

10

Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.

Pantazis P, Early JA, Mendoza JT, DeJesus AR, Giovanella BC. Pantazis P, et al. Among authors: mendoza jt. Cancer Res. 1994 Feb 1;54(3):771-6. Cancer Res. 1994. PMID: 8306340

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters